Skye Bioscience, Inc. (SKYE)
1.09
-0.06
(-5.22%)
USD |
NASDAQ |
Dec 12, 16:00
1.095
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Research and Development Expense (Quarterly): 9.178M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 0.379M |
| Harrow, Inc. | 3.323M |
| Theravance Biopharma, Inc. | 7.707M |
| Viking Therapeutics, Inc. | 89.95M |
| FibroGen, Inc. | 1.209M |